TY - JOUR
T1 - Physical activity promotion in the primary care setting in pre- and type 2 diabetes - the Sophia step study, an RCT
AU - Rossen, Jenny
AU - Yngve, Agneta
AU - Hagströmer, Maria
AU - Brismar, Kerstin
AU - Ainsworth, Barbara
AU - Iskull, Christina
AU - Möller, Peter
AU - Johansson, Unn Britt
N1 - Funding Information:
We would like to thank Christel Lynch for help with intervention planning and Michael Belyea for assistance with the power calculation. We are also grateful for all the participants fulfilling all the measurements. The study is supported by founding from Sophiahemmet University, Sophiahemmet Foundation, The Swedish Diabetes Foundation, The King Gustaf V and Queen Victoria’s Order of Freemasons research foundation and Vårdalstiftelsen.
Publisher Copyright:
© 2015 Rossen et al.
PY - 2015/7/12
Y1 - 2015/7/12
N2 - Background: Physical activity prevents or delays progression of impaired glucose tolerance in high-risk individuals. Physical activity promotion should serve as a basis in diabetes care. It is necessary to develop and evaluate health-promoting methods that are feasible as well as cost-effective within diabetes care. The aim of Sophia Step Study is to evaluate the impact of a multi-component and a single component physical activity intervention aiming at improving HbA1c (primary outcome) and other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes. Methods/design: Sophia Step Study is a randomized controlled trial and participants are randomly assigned to either a multi-component intervention group (A), a pedometer group (B) or a control group (C). In total, 310 patients will be included and followed for 24 months. Group A participants are offered pedometers and a website to register steps, physical activity on prescription with yearly follow-ups, motivational interviewing (10 occasions) and group consultations (including walks, 12 occasions). Group B participants are offered pedometers and a website to register steps. Group C are offered usual care. The theoretical framework underpinning the interventions is the Health Belief Model, the Stages of Change Model, and the Social Cognitive Theory. Both the multi-component intervention (group A) and the pedometer intervention (group B) are using several techniques for behavior change such as self-monitoring, goal setting, feedback and relapse prevention. Measurements are made at week 0, 8, 12, 16, month 6, 9, 12, 18 and 24, including metabolic and cardiovascular biomarkers (HbA1c as primary health outcome), accelerometry and daily steps. Furthermore, questionnaires were used to evaluate dietary intake, physical activity, perceived ability to perform physical activity, perceived support for being active, quality of life, anxiety, depression, well-being, perceived treatment, perceived stress and diabetes self- efficacy. Discussion: This study will show if a multi-component intervention using pedometers with group- and individual consultations is more effective than a single- component intervention using pedometers alone, in increasing physical activity and improving HbA1c, other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02374788. Registered 28 January 2015.
AB - Background: Physical activity prevents or delays progression of impaired glucose tolerance in high-risk individuals. Physical activity promotion should serve as a basis in diabetes care. It is necessary to develop and evaluate health-promoting methods that are feasible as well as cost-effective within diabetes care. The aim of Sophia Step Study is to evaluate the impact of a multi-component and a single component physical activity intervention aiming at improving HbA1c (primary outcome) and other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes. Methods/design: Sophia Step Study is a randomized controlled trial and participants are randomly assigned to either a multi-component intervention group (A), a pedometer group (B) or a control group (C). In total, 310 patients will be included and followed for 24 months. Group A participants are offered pedometers and a website to register steps, physical activity on prescription with yearly follow-ups, motivational interviewing (10 occasions) and group consultations (including walks, 12 occasions). Group B participants are offered pedometers and a website to register steps. Group C are offered usual care. The theoretical framework underpinning the interventions is the Health Belief Model, the Stages of Change Model, and the Social Cognitive Theory. Both the multi-component intervention (group A) and the pedometer intervention (group B) are using several techniques for behavior change such as self-monitoring, goal setting, feedback and relapse prevention. Measurements are made at week 0, 8, 12, 16, month 6, 9, 12, 18 and 24, including metabolic and cardiovascular biomarkers (HbA1c as primary health outcome), accelerometry and daily steps. Furthermore, questionnaires were used to evaluate dietary intake, physical activity, perceived ability to perform physical activity, perceived support for being active, quality of life, anxiety, depression, well-being, perceived treatment, perceived stress and diabetes self- efficacy. Discussion: This study will show if a multi-component intervention using pedometers with group- and individual consultations is more effective than a single- component intervention using pedometers alone, in increasing physical activity and improving HbA1c, other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02374788. Registered 28 January 2015.
KW - Adults
KW - Behavior change
KW - HbA
KW - Intervention
KW - Metabolic health
KW - Pedometer
UR - http://www.scopus.com/inward/record.url?scp=84936886208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936886208&partnerID=8YFLogxK
U2 - 10.1186/s12889-015-1941-9
DO - 10.1186/s12889-015-1941-9
M3 - Article
C2 - 26164092
AN - SCOPUS:84936886208
SN - 1471-2458
VL - 15
JO - BMC public health
JF - BMC public health
IS - 1
M1 - 647
ER -